September 17,2020: union health minister Dr harsh Vardhan Thursday te koishe desh te 2021 sal shuru huwa samay te COVID-19 vaccine toh olabole ase.
Harsh Vardhan para Rajya sabha te koishe ki “dusra desh nishena india khan bi kaam kuri ase.Three COVID-19 vaccine candidates toh alag alag phase te ase.”
Tai aro koishe ki “Prime Minister Narendra Modi’s guidance bithor te ekta expert group khan etu saikena aro etu te advance planning jai ase.”
Minister para aro bi koishe “ami khan bhabona kuri ase aha sal shuru kura samay te COVID-19 vaccine toh india thakibo.”
Aro koishe ki Zydus Cadila and Bharat Biotech laga duita indigeneous vaccine toh phase 1 khotom kurishe.
Serum Institute of India (SII) khan para aro bi ekbar trial shuru kurishe Drug Controller General of India para clearance paa pichede.
Etu toh kobole para ase ki india toh vaccine candidate named Covishield laga manufacturing partner ase.
Covishield toh University of Oxford’s Jenner Institute’s and AstraZeneca para milikena bonaishe.
Pune-based firm, SII toh India laga 17 trial sites laga trials sai ase. Etu uporte Russian Direct Investment Fund (RDIF) aro Dr Reddy’s Laboratories Limited, global pharmaceutical company headquartered India laga bahar te thaka manishe clinical trial t corporate kuribole nimete aro India te Sputnik V vaccine dibole nimete.
Sputnik V, adenovirus vector-based vaccine, toh Gamaleya Scientific Research Institute of Epidemiology and Microbiology, Russian Direct Investment Fund (RDIF) logote milikena bonaishe aro August 11 te register kurishe.
Add Comment